MGI, a world-leading life science innovator, is committed to enabling effective and affordable healthcare solutions for all. Visit our website for more info.
We are proud to announce the supply of our ultra-high throughput sequencer DNBSEQ-T7RS to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiative. Read more here:
We are proud to announce the commercial availability of its innovative HotMPS reagents* and sequencing instrument** in Germany as of 9 August 2022.
Also, we are happy to bring our proven DNBSEQ™ technology to customers and partners in Germany once again:
Meet Chen Fang; one of our employees in the R&D department that wants to share her experiences
#InsideMGI
with you! Stay tuned for more team members' stories to see how we successfully push the limits in healthcare technology.
We’re proud to share MGI is bringing higher quality and more efficient sequencing to the Next Genetic Center (NGC) in Turkey. Read on to see how our proprietary, high-performance platforms help make genetic diagnosis and precision medicine more accessible:
Did you know genome sequencing can be applied to archaeology? Discover how
#MGI
supported a recent molecular archaeology research of an ancient underwater shipwreck with its high-throughput genetic sequencer.
#MGIEmpowers
We are thrilled to introduce our new commercial sequencing chemistry HotMPS and have MGI scientists sharing the data performance of HotMPS* on DNBSEQ-G400 and DNBSEQ-T7, including results on applications such as WGS, WES, RNA-seq and third-party libraries:
We are glad to see that the collaboration between Professor
@rajvarshney
and
@MGI_Technology
stands as a shining example of how genomics is revolutionizing agriculture.
Read more about how MGI Boosts Agrigenomics with Sequencing Technology:
What an exciting event at the European Society of Human Genetics 2022! Speakers Lars and István shared the benefits of our DNBSEQ technology and presented data generated using the newly launched HotMPS** chemistry. Don’t fret if you missed it, take a look here for key learnings!
We are delighted to support The African BioGenome Project (AfricaBP), in sequencing of the project’s first plant species based on MGI’s DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology. 🤝
Read more at:
Taniguchi Dental Clinics preventative practices are made more seamless with MGI. Our DNBSEQ™ technology caters to Japan’s local customers’ needs. Thanks to our sequencers at a better cost that provides faster services, the clinic can efficiently treat its customers.
#MGICustomer
Supporting revolutionary research, MGI proudly offers economical and apt sequencing platforms in SAGC's competitive portfolio. With promising technology for the
#MGICustomer
, MGI wants to share the impact of our comprehensive DNBSEQ technology. Read more:
MGI is offering all scientists, researchers, genomic innovators and genomic startups from all over Africa embarking on genomic sequencing projects to take part in the challenge. Follow the instructions to apply:
Winners will be announced on 25 March 2022.
We are excited to share our latest sequencing chemistry, HotMPS*, at the European Society of Human Genetics 2022! Learn all about our vision, the benefits and the data generated from this innovative technology. Don't forget to also stop by our booth X4-662 and meet our EUAF team!
Are you familiar with how
#MGI
DNBSEQ™ is utilized to create core genetic sequencers?
From ultra-high throughput and adaptability to high speed and effectiveness, our comprehensive portfolio of sequencers can accommodate your every sequencing need.
#MGIExplained
We are excited to announce today on the first day of IPO in China the grand opening of a new demonstration laboratory in Tokyo, Japan, serving as an accessible and centralised customer support center for scientific communities:
We are proud to work with
@GNOMIXlab
to empower Australia’s clinical research and translational medicine. We are so happy to hear that how our technology and products are helping our customers and bring more possibilities to the market.
Inviting you to join us for the 17th ICG held this September 2022 in Riga, Latvia and online!
This year's hybrid
#ICG17
brings expert speakers from all over the world to explore the leading edge in science, under the theme OMICS FOR ALL.
Register here:
We are proud to support Brazil's national genomic sequencing project with MGI’s innovative sequencers. The project aims to sequence the complete genomes of thousands of patients with rare diseases and hereditary cancers. Read more at:
MGI is transforming the healthcare ecosystem through Precision Medicine?
#MGIExplained
With our most accurate, cost-effective and flexible sequencing technology*, we aim to harness the vast pool of genetic information to boost patient care! Read more:
Combined with the advantages of our DNBSEQ™ sequencing technology, MGI HotMPS chemistry* has dramatically improved the data efficiency and lowered cost in WGS applications! A vital application so far, now made even more accurate and effective.
#MGI
#WholeGenomeSequencing
#MGI
is continuously advancing our MPS technology to empower the industry towards a full understanding of the human and other species genomes, and to ultimately improve health. Follow us to read more on integral innovations such as our latest HotMPS chemistry.
#MGIInnovates
🎗 Today, on World AIDS Day, we commemorate the global effort to fight HIV/AIDS and highlight the progress made in research and treatment.
💡Come and learn how sequencing contributes to HIV control...
Announcing
#MGI
’s latest Customer Experience Centers and Demo Labs. We’re privileged to have points of accessibility for both staff and visitors to experience our revolutionary technology first-hand globally. Gain access to our newest tools here! Read more:
👏We are proud to see that our DNBSEQ-G400 has played a key role in enabling the publication of over 1800 research articles!
As a versatile desktop sequencer, G400 can provide users with faster, simpler, and more flexible sequencing experience.
More:
We are excited to launch a new revolutionary product DNBSEQ-T20×2 at AGBT, which is an ultra-high throughput sequencer that is capable of producing up to 50,000 WGS per year while enabling a sub $100 human genome era. Read more:
We are proud to announce that the National Genome Project in Indonesia has selected MGI as one of the technology providers for the first phase of its effort towards establishing a credible and accurate population database of 10000 whole genomes. Read more:
We are excited to enter a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.
Read more at:
We're touching down in
#Germany
! Join us for a trip around the world as we learn about the state of genomics in different countries and how
#MGI
is helping to advance access locally. Don't forget to also follow us for more
#MGIAroundTheWorld
.
We are happy to announce the launch of our new central office in Wehrheim, Germany.
It also reflects MGI’s long-standing commitment to leading life science innovations and the priority for deeper engagement with its customers and partners in Europe:
In just 2 days,
#MGI
leaders will take the stage at the
#ICG17
to share more about the findings and progress in innovations on topics such as genomics. Join our leading experts in this conversation by registering here:
#YearInNumbers
: 2022 is a fruitful year for
#MGI
. We have continued to launch pioneering products, empower scientific research, and set global footprints. Let's look back and celebrate the journey towards life science innovation.
#MGI
constantly creates valuable technology which advances sequencing. CoolMPS™ is the first nucleobase-specific antibody-based sequencing chemistry that also evades DNA "scars"! Follow us to read more on integral innovations and their advantages.
#MGIInnovates
Announcing our latest gene sequencer DNBSEQ-G99,
#MGI
's latest innovation goes beyond our vision, offering researchers a flexible and fast sequencing mode with rolling and hybrid operations. Follow us for more advancements in transforming healthcare:
We are delighted to partner with
@imperialcollege
to establish our second overseas Customer Experience Center (CEC) in Europe. This new CEC will allow easier access to our cutting-edge technology locally. Read more here:
We are so excited to announce the opening of our first overseas Customer Experience Center (referred to as CEC Riga) in Riga, Latvia. Located inside MGI Latvia, CEC Riga is the manufacturing center for MGI’s businesses in Europe and Africa. Read more:
Meet MGI at PrecisionMed Exhibition & Summit, in Dubai at Booth
#B10
on 24-25 May.
Meanwhile, welcome to join MGI talk session at 4:15 PM (GMT+4), Tuesday, May 24th, we will have Toby Huang, BD Director, APAC & ME at MGI to talk at this session.
How does
#MGI
empower the development of agriculture?
Using our efficient sequencers, research can now seamlessly be reinforced through
#genomicselection
and identify superior genotypes with improved traits. Follow us to learn more about our technology!
#MGIEmpowered
We caught up with Dr. Rade Drmanac about
#MGI
's future moves in advancing core genomic tools, further development of sequencing chemistry, deep sequencing in clinical care and more- what more would you expect?
🆕 Comment below.
#7YearsofInnovation
We are so excited to celebrate the US commercial launch of our DNBSEQ™ sequencing product line at the American Society of Human Genetics (ASHG) Annual Meeting, from October 25-29, in Los Angeles.
Read more here:
In celebration of
#MGI
's 7th anniversary and 70 years after the discovery of the DNA double helix Structure, we look back at 7 milestones and events that have played an important part in the history to date. See more:
#HappybirthdaytoMGI
#7Yearsinnovation
We are honored to announce the South African distribution channel partnership with
@NextgenSupplies
, aiming to enhance the support and feasibility in providing advanced life science tools for life science research, agriculture, precision medicine and healthcare in South Africa.
#MGI
makes great strides in pandemic control by refining testing efficiency and capacity with our automated & integrated nucleic acid testing platforms. Follow us for pivotal products in pathogen detection, reproductive health, and more!
#MGIInnovates
Join us at the ICG 2023 this weekend in Melbourne for a series fun events at MGI booth 49-50.
✅Big launch on “What If Campaign”
✅Learn at Lunch Mini Talks
✅ Lucky draw game to win a trip to visit our new HQ
Save your spot at:
We are delighted to announce breakthrough WGS prices based on MGI's DNBSEQ-T20×2* and DNBSEQ-T7* ultra-high throughput genetic sequencer at the Revolutionizing Next-Generation Sequencing(5th edition), a VIB tools and technology conference.
Read more at:
We are excited to introduce the new commercial sequencing chemistry, HotMPS*, which has significant advantages of stronger signal, less systematic sequence-based errors and could be compatible with commonly used library preparation methods. Read more:
We are happy to announce that our innovative CoolMPS sequencing chemistry and instruments* will become commercially available in the United States beginning from August 29,2022. More details about the launch will be revealed at the 22nd AGBT. Read more:
Welcome to join us on the 28th of April 2022 at 2 pm (CET) for our online webinar ‘How DNBSEQ enables research to go to infinity and beyond’. - Webinar language will be French and English.
Register now:
We are looking forward to your participation!
Since founded 7 years ago, MGI has been at the forefront of genomics. What role will MGI continue to play in this field? 🧬️
Dr. Radoje Drmanac—MGI's Chief Scientific Officer—might have some answers about what lies ahead.
#7YearsofInnovation
We know that Precision Medicine can Transform the Healthcare Industry.
We are proud to see that how MGI's cutting-age technologies and products have been contributing to unleashing the power of Precision Medicine.
📢 We are thrilled to announce the global launch of our latest innovation, the MGISP-NEX and MGIFLP-L50 automation platforms, at Medlab Asia & Asia Health 2023. It will be available for order starting at the end of September 2023.🚀
Read more at:
MGI has developed Champa LSEA Laboratory, the first 3rd party detection center in Laos, to help combat Covid-19, under the support of the Belt and Road Life Science Economy Alliance (LSEA) and Sithandone Joint Development Co., Ltd. (STD). Read more here:
#MGI
's new DNBSEQ-T20×2*sequencer, which can sequence up to 50,000 WGS a year under $100 per 30x human genome including instrument depreciation, makes it the powerhouse needed to drive any large-scale genome project forward. For more information:
We are proud to announce our joint efforts with
@SA_genomics
to advance genomics research in Australia by introducing the country's first commercial ultra-high throughput sequencer DNBSEQ-T7* through
@Decode_Science
.
Read more:
MGI is proud to announce the launch of our new sequencing chemistry, the DNBSEQ-G400 HotMPS* High-throughput Sequencing Set.
Join us for an insightful launch event at 13:00 (CET) on April 27, 2022.
Mark your calendar here:
Any exciting sequencing projects you’d like to make happen? This challenge might be for you! MGI Great Canadian Sequencing Challenge is now open for submission:
Applicants who have submitted their applications by May 31, 2022, will stand a chance to win.
New Product - MGIEasy Stool Microbiome DNA Extraction Kit.
The kit is designed for extracting and purifying high quality microbial gDNA from fresh and frozen human stool samples. Find out more here:
Meet our DNBSEQ-T20×2, which is a fully automated sequencing factory that can produce up to 50,000 WGS per year and drive down sequencing cost to a sub $100 price per genome as a trailblazer. Learn more details at:
We are happy to celebrate the opening of its Customer Experience Center (CEC) in South Korea. In partnership with BMS, the new CEC based in Cheonan aims to provide local customers and partners with the first-hand access to MGI's cutting-edge products.
We love to hear how our technology is helping our customers.
We are proud that MGI DNBSEQ™ platforms* empower Taniguchi Dental Clinics to support the Japan Genome Market. Read more:
@tani13110426
@GenomeLead
#MGI
is embracing a new exciting sub-$100 human genome era with overwhelmingly positive reviews on our latest DNBSEQ-T20×2, announced earlier this year at
#AGBT2023
. See what the world has to say about this ultra-high throughput sequencer!
Discover more:
#BGI
announced it has developed a real-time fluorescent RT-PCR kit for detecting the 2019 novel
#coronavirus
. The kits have already been issued to multiple hospitals and disease control centers. Read more:
We are excited to officially launch our DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. This model will be available for reservation overseas starting early 2023. Read the full article here:
We are ready to kick-off the Advances in Genome Biology and Technology (AGBT) General Meeting.
What’s all the hype about? Find out tomorrow, you won't want to miss it! Our unveiling will happen at
#AGBT2023
, Suite
#318
.
For more details:
We are proud to support the completion of nearly 60,000 samples for the
#MMHP
Project, aiming to sequence and analyze microbial DNA from a million human samples to build a microbiome map of the human body and the world's largest human microbiome database.
#DYK
MGI brought the world’s first high-throughput laboratory automated system for sample processing to life? Follow us to learn more about the MGISTP-7000 and our other laboratory automated technology:
#MGIExplained
MGI proudly provides its High-throughput Genetic Sequencer DNBSEQ-T7* and MGISP-100 Automated Sample Preparation System for National Institute for Genomics and Advanced Biotechnology (NIGAB), Pakistan.
#MGI
just launched three new products for smart, portable and flexible genetic
#sequencing
: The one-stop solution includes a small benchtop sequencer, a modular “digital biolab” and a
#SingleCell
sample system that fits into a pocket! Check out the news:
Curious about the innovative inflatable
#labs
? Here comes the reveal of what's inside these labs. They are equipped with MGI's automated sample preparation system and can process up to 10,000 samples per day, one of the keys to an effective testing solution for
#COVID19
.
The fields of genomics have been revolutionized since the first set of human genome was mapped 20 years ago, costing 3 billion at times.
Now, with
#MGI
's latest release of DNBSEQ-T20×2*, sequencing cost has fallen under $100- opening up new opportunities for genetic research.
Twice the speed at half the cost -- that is the kind of innovation our new T7 sequencer is delivering. Beating Moore's law to make affordable high quality genomes a reality for all.
Learn about DNBSEQ-T7:
#MGI
#BGI
#NGS
#DNBSEQ
#genomics
BGI Research and
#MGI
announced a new project to sequence and analyze 10 million cells in collaboration with scientists around the world, aiming to build a comprehensive
#SingleCell
transcriptome map to be shared with the scientific community. Details:
Discover how
#MGI
empowers future microbiome-based interventions for treating disease and supporting health by building the world's largest human microbiome database. Read more:
Stay tuned for more
#MGIExplained
and let us know what we should unravel next.
#MGI
's new CoolMPS™ antibody-based
#sequencing
chemistry has been getting great reviews for improving data quality. This video provides an introduction to how it works.
The RNA Research Center of IBS at Seoul National University and the Korea CDC used
#MGI
’s DNBSEQ™
#sequencing
with Nanopore single-molecule sequencing to present a high-resolution map of the
#SARSCoV2
transcriptome and epitranscriptome. Read preprint:
A 2000-sq-meter emergency detection laboratory operated by
#BGI
is up and running in Wuhan to accelerate testing for
#2019ncov
. In an all-out push with hundreds of volunteers, the main laboratory construction was completed in just five days. Read more:
On
#WorldAIDSDay
,
#MGI
highlights the role of genomics in the advancement of HIV research, diagnosis and treatments. Our cutting-edge technology and tools are supporting the global community in HIV/AIDS prevention and control.
#MGIEmpowers
BGI is donating an additional 100,000
#2019nCoV
test kits in China to support the fight against the 2019 novel
#coronavirus
. The real-time fluorescent RT-PCR kit delivers results in a few hours to support rapid response to the outbreak. Kudos to our hardworking team in
#Wuhan
!
Today MGI is announcing the first commercial delivery of DNBSEQ-T7, the highest throughput sequencer to date, to WeGene and BGI Tech. Happy 20th anniversary, BGI Group!
#BGI20th
#BGI
#Genomics
#MGI
#innovation
#sequencing
Read the news:
We are pleased to announce the winners of our NGS Grant Program:
· Dr Ruby Lin, Westmead Institute for Medical Research
· Dr Subir Sarker, La Trobe University
· Dr Yi Zhou, University of Adelaide
Congratulations to all the successful recipients!
#BGI
Research launched the Million Microbiome of Humans Project w/ partners from China, Sweden, Denmark, France and Latvia. Using
#MGI
's DNBSEQ microbial
#genome
#sequencing
technology, it aims to build the world's largest human
#microbiome
database. News:
There's still time! Applications remain open for DNBSEQ™ MPS Research Grant. The $100,000-worth grant aims to support APAC scientists to develop proof-of-concept programs towards an innovative application. Apply here
#DNBSEQ
#MGIAUDemoLab
@Decode_Science
Korean researchers compared
#MGI
's DNBSEQ-T7 with competing
#sequencing
platform for
#WGS
. The verdict? "We conclude that the MGI platforms can be used for a wide range of
#genomics
research fields at approximately half the cost of the Illumina platforms."
#MGI
now has its first commercial genetic sequencer operating in Australia at Micromon Genomics' top
#NGS
facility at Monash University in Melbourne. Our DNBSEQ™ platform offers great flexibility, affordability and the highest quality for
#ANZ
customers.
The Garvan Institute of Medical Research compared
#MGI
and Illumina technology for single-cell RNA seq and the results are clear: highly comparable performance, but MGI is more cost-effective.
Read more here:
#DNBSEQ
#NGS
#singlecell
#RNA
#sequencing
MGI's new DNBelab D digital biolab + DNBSEQ E express sequencer are customizable to automate
#sequencing
workflows, from
#metagenomics
to targeted panels. These portable, flexible cubes are expandable from a single standalone system to multiple modules for higher throughput.
#DNA
In response to the emergence of the highly contagious COVID-19 Delta variant in Victoria, Australia, MGI is proud to be the supplier for Pathology Queensland’s testing equipment and kits to help safeguard the people living in Queensland.
For more info:
What's going on behind
#SARSCoV2
? A study led by
#BGI
researchers and partners in Guangdong has shown both viral and bacterial co-infections in
#COVID19
#patients
, especially individuals presenting with severe
#disease
. Learn more at
Today, our
#MGI
around the World series will go to
#Africa
. Here we have before and after pictures of setting up inflatable labs in
#Gabon
. In the fight against
#COVID19
, these labs have enabled
#testing
sites to be rapidly set up and process samples at impressive capacity.
We are excited to announce that our innovative HotMPS sequencing chemistry* and instrument** are commercially available in the United Kingdom, from 23rd June 2022. Find out more here:
MGI now has market clearance for its G & T Series
#sequencers
in APAC and Europe. DNBSEQ-T7, DNBSEQ-G400 and DNBSEQ-G50 are now cleared in countries recognizing the CE-IVD mark, so
#MGI
can serve more large-scale population
#sequencing
projects.
Read more:
Fantastic to see the strong turnout for our Technology Breakthrough Talk at
#AGBT19
given by Roy Tan, GM of MGI Americas, introducing
#MGI
's new CoolNGS chemistry to improve throughput, accuracy and cost effectiveness of sequencing. With NHGRI Director Eric D. Green
#genomics
BGI's real-time fluorescent RT-PCR kit for detecting the 2019 novel
#coronavirus
delivers results in 3 hours. In Brunei, a same day diagnosis helped the local lab confirm a negative result for one anxious person from China under quarantine for possible
#nCoV2019
.
Enthusiastic review of our new CoolMPS
#sequencing
chemistry for
#WGS
on DNBSEQ™ by Dr. Nik Matthews, Genomic Manager of the Tumour Profiling Unit at UK Institute of Cancer Research: “It completely blew me away,” he said about his first look at the data.
#AGBT20
#genomics
We are sharing more of our
#MGI
in the World series today to feature MGI's work worldwide in fighting against
#COVID19
. Here is a picture of MGI team members working with
#UAE
#scientists
to build a
#laboratory
in 14 days.
Highlights from MGI at SLAS, where we launched our MGISP-960 and MGISP-100 automated sample prep workstations in the global market. MGI is the only liquid handling system producer that is also a genomics sequencing leader
#healthtech
#genomics
#MGI
Applications for free beta tests of MGI's new DNBelab C single cell
#omics
solution are now available! The portable, economical and user-friendly
#singlecell
research solutions fit into a pocket.
#rna
#rnaseq
#MGI
Apply here:
Data: